Date published: 2025-9-9

00800 4573 8000

SCBT Portrait Logo
Seach Input

IL-17REL Inhibitoren

IL-17REL inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the activity of IL-17REL, a member of the interleukin-17 receptor family. IL-17REL, or Interleukin-17 Receptor E-like, is a protein that plays a role in the complex signaling pathways involved in immune responses. While its exact functions are still under investigation, IL-17REL is believed to be involved in modulating immune responses, particularly those related to inflammatory processes. By inhibiting IL-17REL, researchers aim to dissect its specific role within the broader context of immune system regulation and to understand how it interacts with other members of the IL-17 receptor family, which are known to be critical in host defense mechanisms.

The study of IL-17REL inhibitors is important for expanding our knowledge of the intricate network of cytokine signaling that underpins immune system function. These inhibitors are used in various experimental settings to block the activity of IL-17REL and observe the resulting changes in cellular behavior and immune responses. This approach allows scientists to identify the pathways and molecular interactions in which IL-17REL is involved, providing insights into how this receptor contributes to the regulation of inflammation and immune homeostasis. Additionally, understanding the specific actions of IL-17REL through the use of inhibitors can shed light on its potential role in pathological conditions where immune dysregulation is a factor. By studying IL-17REL inhibitors, researchers can gain a deeper understanding of the receptor's function, which may have broader implications for understanding the immune system's balance and how it responds to various stimuli.

Siehe auch...

ProduktCAS #Katalog #MengePreisReferenzenBewertung

Apilimod

541550-19-0sc-480051
sc-480051A
100 mg
1 g
$420.00
$2600.00
5
(0)

Apilimod ist ein selektiver PIKfyve-Inhibitor, der intrazelluläre Signalwege unterbrechen kann, die mit der Achse der Interleukin-17 (IL-17)-Rezeptorfamilie verbunden sind, indem er den endosomalen Transport verändert und so die durch die Interleukin-17 (IL-17)-Rezeptorfamilie vermittelte Signalübertragung abschwächt.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin ist ein PI3K-Inhibitor, der die Signalübertragung der Interleukin-17 (IL-17)-Rezeptorfamilie indirekt über seine Rolle im PI3K-Akt-Signalweg, der sich mit den IL-17R-Signalwegen überschneidet, verringern kann.